We describe an 81-year-old woman with metastatic renal cell carcinoma who did not recover from life-threatening interstitial pneumonitis induced by everolimus therapy. She received everolimus due to disease progression after sunitinib, but 2 months after starting everolimus treatment, she visited the emergency department after developing a sudden fever and dyspnea. Chest CT revealed diffuse ground-glass opacities, thickening of the interlobular septa, and consolidation throughout both lung fields. The diagnosis was surmised to be everolimus-induced interstitial pneumonitis. Everolimus administration was stopped and 3 courses of steroid pulse therapy were administered, along with intensive care, but the patient died due to rapid respiratory ...
Patients treated for lung cancer may develop lung toxicity induced by chemotherapy (DILD), radiation...
AbstractLike sirolimus, everolimus is an inhibitor of mTOR (mammalian target of rapamycin), used as ...
Leflunomide (LEF) induced interstitial pneumonitis is a very rare condition but potentially fatal. W...
Objective: To elucidate the patterns of interstitial lung disease during everolimus treatment in pat...
Altmış yedi yaşında kadın hasta bir aydır halsizlik, nefes darlığı ve öksürük yakınması ile başvurdu...
Interstitial lung disease (ILD) is a common side effect of the mechanistic target of rapamycin inhib...
Everolimus has important clinical activity in various malignancies, but its use can be complicated b...
A 49-year-old Japanese man visited our institution for the treatment of metastatic rectal cancer. He...
OBJECTIVE: To report a case of fatal alveolar hemorrhage associated with the use of everolimus in a ...
PurposeTo assess the incidence and radiographic and clinical presentation of pneumonitis associated ...
Background Everolimus-related interstitial lung disease (ILD) (also: pneumonitis) poses a difficulty...
Everolimus (RAD 001) is an orally administered inhibitor of mTOR (mammalian target of rapamycin), a ...
Background: Drug-induced interstitial lung disease (DIILD) is a form of interstitial lung disease re...
Although pneumothorax has been reported to be a major pulmonary adverse event in patients treated wi...
Item does not contain fulltextThe use of inhibitors of the mammalian target of rapamycin (mTORi) in ...
Patients treated for lung cancer may develop lung toxicity induced by chemotherapy (DILD), radiation...
AbstractLike sirolimus, everolimus is an inhibitor of mTOR (mammalian target of rapamycin), used as ...
Leflunomide (LEF) induced interstitial pneumonitis is a very rare condition but potentially fatal. W...
Objective: To elucidate the patterns of interstitial lung disease during everolimus treatment in pat...
Altmış yedi yaşında kadın hasta bir aydır halsizlik, nefes darlığı ve öksürük yakınması ile başvurdu...
Interstitial lung disease (ILD) is a common side effect of the mechanistic target of rapamycin inhib...
Everolimus has important clinical activity in various malignancies, but its use can be complicated b...
A 49-year-old Japanese man visited our institution for the treatment of metastatic rectal cancer. He...
OBJECTIVE: To report a case of fatal alveolar hemorrhage associated with the use of everolimus in a ...
PurposeTo assess the incidence and radiographic and clinical presentation of pneumonitis associated ...
Background Everolimus-related interstitial lung disease (ILD) (also: pneumonitis) poses a difficulty...
Everolimus (RAD 001) is an orally administered inhibitor of mTOR (mammalian target of rapamycin), a ...
Background: Drug-induced interstitial lung disease (DIILD) is a form of interstitial lung disease re...
Although pneumothorax has been reported to be a major pulmonary adverse event in patients treated wi...
Item does not contain fulltextThe use of inhibitors of the mammalian target of rapamycin (mTORi) in ...
Patients treated for lung cancer may develop lung toxicity induced by chemotherapy (DILD), radiation...
AbstractLike sirolimus, everolimus is an inhibitor of mTOR (mammalian target of rapamycin), used as ...
Leflunomide (LEF) induced interstitial pneumonitis is a very rare condition but potentially fatal. W...